Champions Oncology
CSBR
33 hedge funds and large institutions have $32.4M invested in Champions Oncology in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.03% less ownership
Funds ownership: 51.36% → 49.33% (-2%)
11% less funds holding
Funds holding: 37 → 33 (-4)
31% less capital invested
Capital invested by funds: $46.7M → $32.4M (-$14.3M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
+$357K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$109K |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$40.9K |
| 4 |
Renaissance Technologies
New York
|
+$28.5K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$508K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$500K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$445K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$179K |
CSBR Hedge Fund Activity: Q3 2019 in Review
33 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2019, worth a combined $32.4M — down 31% from $46.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CSBR and 2 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Tocqueville Asset Management, adding an estimated $357K. The largest seller was Allianz Asset Management, exiting entirely with an estimated $508K sold.
- 33 institutional investors held Champions Oncology (CSBR) as of Q3 2019, down from 37 in Q2 2019.
- Funds reported $32.4M of Champions Oncology stock for Q3 2019, down 31% quarter-over-quarter.
- 2 funds opened new Champions Oncology positions in Q3 2019 and 6 closed out, a net change of -4 holders.
- The largest Champions Oncology buyer in Q3 2019 was Tocqueville Asset Management, an estimated $357K added.
- The largest Champions Oncology seller in Q3 2019 was Allianz Asset Management, an estimated $508K sold.
Based on aggregated 13F filings for Q3 2019.